Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
12. November 2024 08:00 ET
|
Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
Upswing Health Rounds Out Advisory Board to Drive AI-Powered Virtual Orthopedic Care
22. Oktober 2024 13:57 ET
|
Upswing Health
Upswing Health Rounds Out Advisory Board members with Brian Klepper, PhD and Doug Geinzer to Drive AI-Powered Virtual Orthopedic Care
Medical Products Market to hit USD 41.1 billion by 2032, says Global Market Insights Inc.
10. Oktober 2024 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Medical Products Market size was valued at USD 25.2 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032, driven...
AOFAS Annual Meeting 2024 Highlights Orthopaedic Research and Innovation
24. September 2024 14:00 ET
|
American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Sept. 24, 2024 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American...
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
09. September 2024 15:50 ET
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
05. September 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus...
Autologous Cell Therapy Market Estimated to Grow USD 34.7 Billion by 2027, Rising at a 18.1% CAGR- Transparency Market Research, Inc.
21. August 2024 11:09 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. , Aug. 21, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR), the global autologous cell therapy market...
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
20. August 2024 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to...
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
19. August 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, proudly unveils its Scandinavian Total Ankle Replacement (STAR®...
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
12. Juli 2024 08:00 ET
|
Enovis Corporation
AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today the...